Medicis Settles Patent Dispute
December 02, 2008 at 13:22 PM EST
Medicis Pharmaceutical Corp. (NYSE: MRX) settled a patent dispute over a generic acne drug with Impax Laboratories sending the stock price soaring $2.77 to $13.89.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.